Seelos Therapeutics

YTD

ALL

Why Robinhood?

You can watch SEEL and buy or sell other stocks, ETFs, and their options commission-free!

About SEEL

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders.

CEO

Raj Mehra, PhD, MBA

CEORaj Mehra, PhD, MBA

Employees

—

Employees—

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

1987

Founded1987

Employees

—

Employees—

SEEL Key Statistics

Market cap

174.43K

Market cap174.43K

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

18.50

Average volume18.50

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$1.34

52 Week high$1.34

52 Week low

—

52 Week low—

People also own

Based on the portfolios of people who own SEEL. This list is generated using Robinhood data, and it’s not a recommendation.

Mind Medicine (MindMed)